Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 486,000 | 329,000 | 248,000 | 192,320 | N/A |
| Marketable Securities | 87,000 | 86,000 | 137,000 | 278,580 | N/A |
| Receivables | 622,000 | 626,000 | 621,000 | 1,011,320 | N/A |
| Inventories | 1,171,000 | 1,156,000 | 1,123,000 | 995,320 | N/A |
| Other current assets | 363,000 | 342,000 | 389,000 | 20 | 0 |
| TOTAL | $2,729,000 | $2,539,000 | $2,518,000 | $2,477,560 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 159,000 | 156,000 | 163,000 | 165,960 | 0 |
| Other Non-Current Assets | 155,000 | 172,000 | 191,000 | 33,520 | 0 |
| TOTAL | $314,000 | $328,000 | $354,000 | $199,480 | $N/A |
| Total Assets | $5,871,000 | $5,591,000 | $5,575,000 | $5,241,640 | $5,319,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 122,000 | 133,000 | 115,000 | 153,610 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 97,990 | N/A |
| Other current liabilities | 886,000 | 832,000 | 859,000 | 639,160 | N/A |
| TOTAL | $1,200,000 | $1,091,000 | $1,151,000 | $1,039,360 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 123,000 | 117,000 | 127,000 | 114,750 | N/A |
| aiOther Non-Current Liabilities | 62,000 | 57,000 | 54,000 | 66,140 | 0 |
| TOTAL | $439,000 | $431,000 | $462,000 | $358,130 | $N/A |
| Total Liabilities | $1,639,000 | $1,522,000 | $1,613,000 | $1,397,500 | $1,666,070 |
| Shareholders' Equity | |||||
| Common Shares | 117,000 | 116,000 | 117,000 | 108,050 | N/A |
| Retained earnings | 3,656,000 | 3,516,000 | 3,400,000 | 3,214,420 | N/A |
| Other shareholders' equity | 43,000 | 24,000 | 27,000 | 135,760 | 3,653,620 |
| TOTAL | $4,232,000 | $4,069,000 | $3,962,000 | $3,844,130 | $3,653,620 |
| Total Liabilities And Equity | $5,871,000 | $5,591,000 | $5,575,000 | $5,241,630 | $5,319,690 |